MODULATING THE ECS CAN HAVE THERAPEUTIC POTENTIAL IN ALMOST ALL HUMAN DISEASES.

The Endocannabinoid System (ECS) is one of the largest homeostatic systems in the human body, with elements throughout the brain and in every major organ. Scientific research has shown that changes in ECS activity may correlate with a wide range of disease states.

Recent Posts

Phytecs Expands Scientific Advisory Board with Leading Experts in Mental Health, Inflammation, Metabolism and the Endocannabinoid System

LOS ANGELES--(BUSINESS WIRE)--Phytecs, Inc., a biotechnology company exploring potential therapies that target the body’s endocannabinoid system (ECS) to treat disease, today announced the addition of…

Phytecs Presents New Data on Fluorinated Cannabidiol Derivatives

WASHINGTON--(BUSINESS WIRE)--Phytecs, Inc., a biotechnology company exploring innovative research into and potential treatments targeting the endocannabinoid system (ECS), announced new findings from its study of…

Phytecs, Leading U.S. Biotech Focused on the Endocannabinoid System, Partners with Yissum to Discover New ECS-Targeting Compounds, Test Potential of Fluorinated CBD

Professor Raphael Mechoulam, cannabinoid science pioneer, will lead team testing potential of existing proprietary compounds and identifying new compounds targeting specific elements of ECS LOS…